论文部分内容阅读
目的了解不同抗生素方案治疗儿童下呼吸道感染的药学经济学价值。方法回顾性分析我院2012年12月~2013年12月收治的120例下呼吸道感染儿童的临床资料,随机分成实验组与对照组各60例,分别予以头孢曲松钠、头孢替安抗生素治疗,结合药学经济学,采用最小成本分析法,评价治疗方法与效果。结果两组治疗总有效率依次为93.33%、80%,成本分别为41.6元、259.82元,成本-效果比依次为0.45、3.25,两种药物成本-效果比值差异具有显著统计学意义(P<0.05)。结论头孢曲松钠治疗儿童下呼吸道感染疗效最佳,成本-效果比值最低,值得临床广泛应用。
Objective To understand the pharmacoeconomic value of different antibiotic regimens in treating children with lower respiratory tract infection. Methods The clinical data of 120 children with lower respiratory tract infection admitted to our hospital from December 2012 to December 2013 were retrospectively analyzed. They were randomly divided into experimental group and control group, 60 cases each. Ceftriaxone sodium and cefotiam antibiotics , Combined with pharmacoeconomics, the use of minimum cost analysis, evaluation of treatment methods and effects. Results The total effective rates of the two groups were 93.33% and 80% respectively, the costs were 41.6 yuan and 259.82 yuan, respectively, and the cost-effectiveness ratios were 0.45 and 3.25 respectively, with significant difference between the two drugs in cost-effectiveness ratio (P < 0.05). Conclusion Ceftriaxone sodium treatment of children with lower respiratory tract infection the best effect, the lowest cost-effectiveness ratio, it is widely used in clinical.